Jiecheng Ye
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Novel NOTCH2-NTRK1 fusion confers osimertinib resistance in EGFR-mutant non-small cell lung cancer by interacting with EGFR.
Journal: Translational oncology
Published: July 19, 2025
Phase separation of DDX21 promotes colorectal cancer metastasis via MCM5-dependent EMT pathway.
Journal: Oncogene
Published: November 29, 2022
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway.
Journal: International journal of oncology
Published: March 17, 2022
TYMS-TM4SF4 axis promotes the progression of colorectal cancer by EMT and upregulating stem cell marker.
Journal: American journal of cancer research
Published: January 13, 2022
Development and Validation of a Ferroptosis-Related Gene Signature and Nomogram for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma.
Journal: Frontiers in genetics
Published: April 19, 2021
A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage.
Journal: Biochemical pharmacology
Published: January 15, 2019
Vasorin stimulates malignant progression and angiogenesis in glioma.
Journal: Cancer science
Published: January 07, 2019
Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma.
Journal: International journal of clinical and experimental pathology
Published: September 11, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026